Zobrazeno 1 - 10
of 94
pro vyhledávání: '"DM Lynch"'
Publikováno v:
Journal of the American Podiatric Medical Association. 88:375-380
A randomized, prospective study was conducted to compare the individual effectiveness of three types of conservative therapy in the treatment of plantar fasciitis. One hundred three subjects were randomly assigned to one of three treatment categories
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::993777c766dc4391ef6799783ecce2b7
https://doi.org/10.7547/87507315-88-8-375
https://doi.org/10.7547/87507315-88-8-375
Publikováno v:
Blood. 66(5)
Sera from four patients with heparin-associated thrombocytopenia (HAT) were evaluated by a quantitative enzyme-linked immunosorbent assay (ELISA) to detect heparin-dependent serum platelet-bindable immunoglobulin (S-PBIg) and by Western blotting and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84c49f23c12e724357dbac244fd69df5
https://pubmed.ncbi.nlm.nih.gov/4052632
https://pubmed.ncbi.nlm.nih.gov/4052632
Publikováno v:
Transfusion. 24(4)
An enzyme-linked immunosorbent assay (ELISA) using F(ab')2 peroxidase- labeled antihuman immunoglobulin and o-phenylenediamine dihydrochloride (OPD) as a substrate was developed to measure serum platelet bindable IgG (S-PBIgG). The assay was made qua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd9e65aad1a50cebcb4ae1b45314ae2f
https://pubmed.ncbi.nlm.nih.gov/6235647
https://pubmed.ncbi.nlm.nih.gov/6235647
Autor:
Huang GX; Division of Allergy & Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: ghuang8@mgb.org., Merz LE; Division of Transplantation and Cellular Therapy, Dana Farber Cancer Institute, Boston, Massachusetts., Mehta GD; Allergy & Immunology, UMass Memorial Medical Center, Worcester, Massachusetts., Marquis KD; Division of Allergy & Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts., Besz K; Division of Allergy & Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts., Lynch DM; Division of Allergy & Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts., Cutler C; Division of Transplantation and Cellular Therapy, Dana Farber Cancer Institute, Boston, Massachusetts., Castells MC; Division of Allergy & Clinical Immunology, Brigham and Women's Hospital, Boston, Massachusetts.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Nov; Vol. 30 (11), pp. 1112.e1-1112.e9. Date of Electronic Publication: 2024 Sep 04.
Autor:
Kroupova A; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK., Spiteri VA; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK., Rutter ZJ; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK., Furihata H; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK., Darren D; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK.; Cancer Science Institute Singapore, National University of Singapore, Singapore, 117599, Singapore., Ramachandran S; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK.; Biocon BMS R&D Center, Bommasandra Industrial Area, Bommasandra, Karnataka, 560099, India., Chakraborti S; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK., Haubrich K; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK., Pethe J; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK.; National Heart and Lung Institute, Imperial College London, London, SW3 6LY, UK., Gonzales D; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK.; Institute of Cell Biology, University of Edinburgh, Edinburgh, EH9 3BF, UK., Wijaya AJ; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK.; PT Kalbe Farma, Jl. Let. Jend Suprapto Kav 4, Kalbe Farma, Jakarta, 10510, Indonesia., Rodriguez-Rios M; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK., Sturbaut M; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK., Lynch DM; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK., Farnaby W; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK., Nakasone MA; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK., Zollman D; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK. d.l.zollman@dundee.ac.uk., Ciulli A; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, Dundee, DD1 5JJ, UK. a.ciulli@dundee.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2024 Oct 15; Vol. 15 (1), pp. 8885. Date of Electronic Publication: 2024 Oct 15.
Autor:
Jabaley T; Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana Farber Cancer Institute, Boston, Massachusetts, USA., Menon S; Division of Gyn Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA., Bagley J; Nursing and Patient Care Services, Dana Farber Cancer Institute, 450 Brookline Ave., Boston, Massachusetts, USA., Tuskan J; Nursing and Patient Care Services, Dana Farber Cancer Institute, 450 Brookline Ave., Boston, Massachusetts, USA., Mazzola E; Department of Data Science, Dana Farber Cancer Institute, 450 Brookline Ave., Boston, Massachusetts, USA., Costa J; Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana Farber Cancer Institute, Boston, Massachusetts, USA., Rompelman G; Pharmacy Department, Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, Massachusetts, USA., Servant J; Nursing and Patient Care Services, Dana Farber Cancer Institute, 450 Brookline Ave., Boston, Massachusetts, USA., Corbett M; Nursing and Patient Care Services, Dana Farber Cancer Institute, 450 Brookline Ave., Boston, Massachusetts, USA., Lynch DM; Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, 75 Francis St, Boston, Massachusetts, USA.
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Oct 08, pp. 10781552241288775. Date of Electronic Publication: 2024 Oct 08.
Autor:
Freemantle JB; Division of Cell Signalling and Immunology, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K., Shah D; Division of Cell Signalling and Immunology, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K., Lynch DM; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, 1 James Lindsay Place, Dundee DD1 5JJ, U.K., Ciulli A; Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, 1 James Lindsay Place, Dundee DD1 5JJ, U.K., Hundal HS; Division of Cell Signalling and Immunology, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K., Hardie DG; Division of Cell Signalling and Immunology, Sir James Black Centre, School of Life Sciences, University of Dundee, Dundee DD1 5EH, U.K.
Publikováno v:
The Biochemical journal [Biochem J] 2024 Sep 18; Vol. 481 (18), pp. 1203-1219.
Autor:
Moss C; Centre for Craniofacial Regeneration and Biology, King's College London, London, United Kingdom., Vacca B; Centre for Craniofacial Regeneration and Biology, King's College London, London, United Kingdom., Arnold J; Department of Biological Sciences, University of Chester, Chester, United Kingdom., Hubens C; Centre for Craniofacial Regeneration and Biology, King's College London, London, United Kingdom., Lynch DM; Centre for Craniofacial Regeneration and Biology, King's College London, London, United Kingdom., Pegge J; Centre for Craniofacial Regeneration and Biology, King's College London, London, United Kingdom., Green MAR; Dept of Economics, University of Oxford, Oxford, United Kingdom., Hosie CA; Department of Biological Sciences, University of Chester, Chester, United Kingdom., Smith TE; Department of Biological Sciences, University of Chester, Chester, United Kingdom., Green JBA; Centre for Craniofacial Regeneration and Biology, King's College London, London, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2024 Jul 19; Vol. 19 (7), pp. e0299179. Date of Electronic Publication: 2024 Jul 19 (Print Publication: 2024).
Autor:
Tuttle KL; Division of Pediatric Allergy and Immunology, Department of Pediatrics, Golisano Children's Hospital at Strong Memorial Hospital, University of Rochester, Rochester, NY., Lynch DM; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Boston, Mass., Marquis K; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Boston, Mass; Department of Pharmacy, Brigham and Women's Hospital, Boston, Mass., Besz KM; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Boston, Mass; Department of Pharmacy, Brigham and Women's Hospital, Boston, Mass., Matulonis UA; Division of Gynecologic Oncology, Susan F. Smith Center for Women's Cancers, Dana Farber Cancer Institute, Boston, Mass; Department of Medicine, Harvard Medical School, Boston, Mass., Castells MC; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Boston, Mass; Department of Medicine, Harvard Medical School, Boston, Mass. Electronic address: mcastells@bwh.harvard.edu.
Publikováno v:
The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2024 May; Vol. 12 (5), pp. 1348-1350.e2. Date of Electronic Publication: 2024 Feb 18.
Autor:
Jimenez-Rodriguez TW; Allergy Section, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; ARADyAL Spanish Network (RD16/0006), Instituto de Salud Carlos III (ISCIII), Fundación Española para la Ciencia y la Tecnología (FECyT), Madrid, Spain., de Las Vecillas L; Allergy Section, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain.; Department of Allergy, La Paz University Hospital, IdiPAZ, Madrid, Spain., Labella M; ARADyAL Spanish Network (RD16/0006), Instituto de Salud Carlos III (ISCIII), Fundación Española para la Ciencia y la Tecnología (FECyT), Madrid, Spain.; Allergy Clinical Unit, Hospital Regional Universitario de Málaga, Málaga, Spain.; Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain., Lynch DM; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Besz KM; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Marquis K; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Burgos A; Pharmacy Department, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Soriano Gomis V; Allergy Section, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; ARADyAL Spanish Network (RD16/0006), Instituto de Salud Carlos III (ISCIII), Fundación Española para la Ciencia y la Tecnología (FECyT), Madrid, Spain.; Department of Clinical Medicine, Miguel Hernández University, Alicante, Spain., Lozano I; Oncology Section, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Antón RAM; Oncology Day Hospital Nursing Service, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., de la Calle FM; Immunology Section, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., González Delgado MP; Allergy Section, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; ARADyAL Spanish Network (RD16/0006), Instituto de Salud Carlos III (ISCIII), Fundación Española para la Ciencia y la Tecnología (FECyT), Madrid, Spain.; Department of Clinical Medicine, Miguel Hernández University, Alicante, Spain., Gutiérrez A; Allergy Section, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain., Montenegro E; Allergy Section, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain., Rodríguez F; Allergy Section, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain., Fernández Sánchez FJ; Allergy Section, Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain.; ARADyAL Spanish Network (RD16/0006), Instituto de Salud Carlos III (ISCIII), Fundación Española para la Ciencia y la Tecnología (FECyT), Madrid, Spain.; Department of Clinical Medicine, Miguel Hernández University, Alicante, Spain., Castells M; Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Allergy [Allergy] 2024 Mar; Vol. 79 (3), pp. 679-689. Date of Electronic Publication: 2023 Nov 02.